Table 1.
ITFMWM | Placebo | Non-Injured | |
---|---|---|---|
Gender Male (n) Female (n) |
19 6 |
17 7 |
11 15 |
Age (years) | 23 (2.5) | 21.7 (1.74) | 22.3 (2.11) |
Weight (kg) | 70.2 (10.48) | 71.5 (11.3) | 64.9 (11.38) |
Height (cm) | 176.4 (9.24) | 177.9 (8.94) | 172.5 (8,61) |
Sport activity (hour) | 5.4 (3.8) | 5,3 (4.43) | 3.5 (3.13) |
Elasticity (N.m rad−1) | 36.5 (18.05) | 33.8 (15.69) | 37.2 (14.79) |
Viscosity (N.m.s rad−1) | 6.9 (3.69) | 8.2 (3.99) | 5.8 (3.04) |
Lpath (N.m rad−1) | 118.2 (37.59) | *135.3 (54.92) | *99.8 (31.77) |
WBLT distance (cm) | 11.6 (3.33) | 12.5 (3.33) | 11.4 (3.24) |
Pain (VAS,/10) | 1.7 (1.49) | 1.1 (1.18) | 0.8 (1.06) |
Stiffness perception (/10) | 4.6 (1.68) | 3.9 (1.72) | 4.1 (1.87) |
Results are presented as means (SD). ITFMWM: inferior tibiofibular mobilization with movement; WBLT: weight-bearing lunge test (toe-to-wall distance); VAS: visual analogue scale; Lpath: path length or total stiffness representation. *One-way ANOVA demonstrates significant differences between marked groups (i.e. placebo and non-injured Lpath baseline values).